DE60003943D1 - Trimegestone enthaltende pharmazeutische zusammensetzungen - Google Patents

Trimegestone enthaltende pharmazeutische zusammensetzungen

Info

Publication number
DE60003943D1
DE60003943D1 DE60003943T DE60003943T DE60003943D1 DE 60003943 D1 DE60003943 D1 DE 60003943D1 DE 60003943 T DE60003943 T DE 60003943T DE 60003943 T DE60003943 T DE 60003943T DE 60003943 D1 DE60003943 D1 DE 60003943D1
Authority
DE
Germany
Prior art keywords
trimegestone
pharmaceutical compositions
containing pharmaceutical
composition
concerns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60003943T
Other languages
English (en)
Other versions
DE60003943T2 (de
Inventor
Philippe Becourt
Robert Georges
Chicq Serge Segot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE60003943D1 publication Critical patent/DE60003943D1/de
Application granted granted Critical
Publication of DE60003943T2 publication Critical patent/DE60003943T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60003943T 1999-11-23 2000-11-22 Trimegestone enthaltende pharmazeutische zusammensetzungen Expired - Lifetime DE60003943T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9914714 1999-11-23
FR9914714A FR2801218B1 (fr) 1999-11-23 1999-11-23 Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
PCT/FR2000/003240 WO2001037841A1 (fr) 1999-11-23 2000-11-22 Compositions pharmaceutiques comprenant de la trimegestone

Publications (2)

Publication Number Publication Date
DE60003943D1 true DE60003943D1 (de) 2003-08-21
DE60003943T2 DE60003943T2 (de) 2004-05-27

Family

ID=9552429

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60003943T Expired - Lifetime DE60003943T2 (de) 1999-11-23 2000-11-22 Trimegestone enthaltende pharmazeutische zusammensetzungen

Country Status (11)

Country Link
US (1) US7732431B2 (de)
EP (1) EP1235579B1 (de)
JP (1) JP5060005B2 (de)
AT (1) ATE245028T1 (de)
AU (1) AU1869601A (de)
DE (1) DE60003943T2 (de)
DK (1) DK1235579T3 (de)
ES (1) ES2200978T3 (de)
FR (1) FR2801218B1 (de)
PT (1) PT1235579E (de)
WO (1) WO2001037841A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306846A (en) * 2002-04-03 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200306196A (en) * 2002-04-03 2003-11-16 Wyeth Corp Hormone replacement therapy
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
CA2615427A1 (en) * 2005-07-20 2007-01-25 Oliver Gloger Oral contraception with trimegestone
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston
EP2108371A1 (de) * 2008-04-08 2009-10-14 Grünenthal GmbH Estra-1,3,5(10)-trien-Derivate zur Kontrazeption
US9271991B2 (en) 2010-10-27 2016-03-01 Dignity Health Trimegestone (TMG) for treatment of preterm birth
EP3019172B1 (de) 2013-07-11 2019-09-25 Evestra, Inc. Verbindungen zur herstellung von prodrugs
SG11201906735RA (en) 2017-01-23 2019-08-27 Regeneron Pharma Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof
MX2019012169A (es) * 2017-04-11 2019-12-11 Regeneron Pharma Ensayos para evaluar la actividad de moduladores de miembros de la familia de hidroxiesteroide (17-beta) deshidrogenasa (hsd17b).
KR20200062314A (ko) 2017-10-11 2020-06-03 리제너론 파마슈티칼스 인코포레이티드 Pnpla3 i148m 변이를 발현하는 환자의 간 질환의 치료에서의 hsd17b13의 저해
WO2019078983A1 (en) 2017-10-19 2019-04-25 Evestra, Inc. CONTRACEPTIVES OF PROGESTINE PRODRANT WITH EXTENDED ACTION
WO2019183164A1 (en) 2018-03-21 2019-09-26 Regeneron Pharmaceuticals, Inc. 17β-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4239646A (en) * 1974-09-23 1980-12-16 Champion International Corporation Microspheric opacifying agents and method for their production
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
FR2692267B1 (fr) * 1992-06-11 1995-05-19 Roussel Uclaf Nouveau procédé de préparation de composés stéroïdes 20-céto 21alpha-hydroxy et intermédiaires.
FR2694007B1 (fr) * 1992-07-23 1994-09-30 Roussel Uclaf Nouveau procédé de préparation de composés stéroïdes 20-céto 21 (S) hydroxy et des intermédiaires.
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
CN1119998C (zh) * 1995-06-22 2003-09-03 阿克佐诺贝尔公司 去氧孕烯的压制干颗粒片
FR2749012B1 (fr) * 1996-05-22 1998-08-07 Hoechst Marion Roussel Inc Nouveaux steroides 1 ou 6-hydroxyles, leur procede de preparation, leur application a titre de medicament et les compositions pharmaceutiques les renfermant
CN1186023C (zh) * 1996-07-26 2005-01-26 惠氏公司 双相避孕方法及包含孕激素和雌激素组合物的药剂盒
BR9710566A (pt) * 1996-07-26 1999-08-17 American Home Prod M-todo anticoncepcional monof sico e um kit compreendendo uma combina-Æo de uma progestina e estrog-nio
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
WO1998004246A2 (en) * 1996-07-26 1998-02-05 American Home Prod Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
WO1998004268A1 (en) * 1996-07-26 1998-02-05 American Home Products Corporation Oral contraceptive
SG125044A1 (en) * 1996-10-14 2006-09-29 Mitsubishi Gas Chemical Co Oxygen absorption composition
US6329416B1 (en) * 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives

Also Published As

Publication number Publication date
JP2003514861A (ja) 2003-04-22
FR2801218B1 (fr) 2001-12-28
WO2001037841A1 (fr) 2001-05-31
ATE245028T1 (de) 2003-08-15
FR2801218A1 (fr) 2001-05-25
ES2200978T3 (es) 2004-03-16
US7732431B2 (en) 2010-06-08
US20070219169A1 (en) 2007-09-20
EP1235579A1 (de) 2002-09-04
DK1235579T3 (da) 2003-10-20
AU1869601A (en) 2001-06-04
EP1235579B1 (de) 2003-07-16
PT1235579E (pt) 2003-12-31
JP5060005B2 (ja) 2012-10-31
DE60003943T2 (de) 2004-05-27

Similar Documents

Publication Publication Date Title
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
MY126897A (en) Anticonvulsant derivatives useful for preventing the development of type ii diabetes mellitus and syndrome x
ES2114487B1 (es) Mezcla estabilizante sinergistica.
MX9700223A (es) Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida.
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
YU15299A (sh) Farmaceutski sastavi
SE9704546D0 (sv) Novel compounds
TR199800077T1 (xx) Kontroll� ��z�len paroksetin terkipleri.
TR200100054T2 (tr) Paroksetin metansülfonat
MY124487A (en) Dolastatin derivatives, their preparation and use
GB2364641A (en) Stabilized oral pharmaceutical composition containing iodide and iodate and method
DE60003943D1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
AU9534398A (en) Novel pharmaceutical composition
ATE240303T1 (de) 1,2,4-triazol-3-thion verbindungen
TR200201459T2 (tr) Okzkarbazepin içeren süspansiyon
AU8332791A (en) Oral pharmaceutical compositions containing melatonin
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
BG101401A (en) Cisaspide extended release oral compositions
BG105539A (en) Eletriptan hydrobromide monohydrate
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
ES2191625T3 (es) Composicion oral que contiene perlita.
IL128500A (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES2179375T3 (es) Composiciones farmaceuticas estabilizadas, a base de quinupristina y de dalfopristina y su preparacion.
MXPA01011296A (es) Composiciones contraceptivas que contienen derivados de indolina y agentes progestacionales.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC